Hair loss–focused Veradermics and cancer biotech Eikon follow the lead of Aktis Oncology, which last week announced a $318 ...
Eikon Therapeutics is planning to become the second biotech to go public in 2026, in another sign that the public markets are ...
BitGo has launched its IPO to raise up to $201 million, targeting a $1.96 billion valuation and over $90 billion in assets ...
Discord, the popular chat and community platform, filed confidential IPO paperwork with the SEC and has pinned its hopes on a ...
Crypto custody firm BitGo seeks to raise $201 million at a $1.9 billion valuation in its US IPO, with listing set for NYSE ...
Not only will an IPO give early backers like Sequoia Capital and TCV a chance to exit, but it means mounting pressure for ...
Brokerages began coverage of Medline with largely bullish ratings on Monday, betting on supply chain strength and brand ...
PETALING JAYA: Impact Capital Holdings Bhd is eyeing a listing on the ACE Market of Bursa Malaysia. The company is ...
Private crypto wallet and custody firm BitGo filed for an initial public offering in the U.S. with aims to raise as much as ...
FPX holds 101 IPO and spin-off stocks in 1,000 days, across tech, industrials, healthcare, strong returns, 14% seasoned via M ...
3don MSN
Billionaire Israel Englander Sells Palantir Stock and Buys an AI Stock Up 27,300% Since Its IPO
Israel Englander, a highly successful hedge fund manager, sold Palantir and bought Tesla in the third quarter.
Using Crunchbase’s predictive intelligence tools — which evaluate factors including funding history, growth signals, investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results